Abegaill
- taking ductoscopy to the next level -
- taking ductoscopy to the next level -
Abegaill B.V. is a young company dedicated to develop medical devices in the field of ductoscopy. The ultimate goal is to treat pre(malignant) breast disease.
Rotterdam, December 21th, 2017 – Abegaill B.V. announces the successfully closing of a seed funding round. This funding is provided by Swanbridge Capital, a Dutch life science venture capital fund, and Leander Healthcare, a Benelux medtech innovation provider. Edwin Leander has been appointed as the company’s CEO.